Sol Epstein

7.2k total citations · 1 hit paper
104 papers, 4.4k citations indexed

About

Sol Epstein is a scholar working on Orthopedics and Sports Medicine, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sol Epstein has authored 104 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Orthopedics and Sports Medicine, 37 papers in Oncology and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sol Epstein's work include Bone health and treatments (35 papers), Bone health and osteoporosis research (35 papers) and Vitamin D Research Studies (19 papers). Sol Epstein is often cited by papers focused on Bone health and treatments (35 papers), Bone health and osteoporosis research (35 papers) and Vitamin D Research Studies (19 papers). Sol Epstein collaborates with scholars based in United States, South Africa and United Kingdom. Sol Epstein's co-authors include Norman H. Bell, Judith Shary, Firhaad Ismail, Mary Joan Oexmann, S. Shaw, A Greene, S. Thomas, Colin Movsowitz, M D Fallon and Michael D. Fallon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Sol Epstein

103 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for alteration of the vitamin D-endocrine system in obese subjects.

1985 552 citations Norman H. Bell, Sol Epstein et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Sol Epstein

Since Specialization

Citations

This map shows the geographic impact of Sol Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sol Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sol Epstein more than expected).

Fields of papers citing papers by Sol Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sol Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sol Epstein. The network helps show where Sol Epstein may publish in the future.

Co-authorship network of co-authors of Sol Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of Sol Epstein. A scholar is included among the top collaborators of Sol Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sol Epstein. Sol Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secondary osteoporosis: Pathophysiology & diagnosis 2014 ·Best Practice & Research Clinical Endocrinology & Metabolism ·(unknown), Sol Epstein	48
2	Basic science and clinical utility of biochemical markers of bone turnover — A congress report^* 2009 ·Experimental and Clinical Endocrinology & Diabetes ·Markus J. Seibel, David J. Baylink, Jonathan Farley, Sol Epstein, M. Yamauchi, Richard Eastell, H.A.P. Pols, Lawrence G. Raisz, Caren M. Gundberg	2
3	Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis 2008 ·Bone ·Y. Kawashima, J. Christopher Fritton, Shoshana Yakar, Sol Epstein, Mitchell B. Schaffler, Karl J. Jepsen, Derek LeRoith	64
4	Rationale and design of the MOTION study (monthly oral therapy with ibandronate for osteoporosis intervention). 2005 ·Journal of Bone and Mineral Research ·Felicia Cosman, Michael R. McClung, Clifford J. Rosen, Sol Epstein, Vipul Devas, (unknown), (unknown), José Zanchetta, Cyrus Cooper, P. D. Delmas	2
5	The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine a-induced osteopenia in rats 2001 ·Calcified Tissue International ·Bali R. Sodam, Emmanuel M. Awumey, (unknown), Sol Epstein	3
6	Interferon-α, unlike interferon-γ, does not cause bone loss in the rat 1999 ·Bone ·Grant R. Goodman, (unknown), (unknown), Hua Zhou, Y.F. Ma, W.S.S. Jee, Sol Epstein	19
7	Improved Strategies for Diagnosis and Treatment of Osteoporosis 1999 ·Menopause The Journal of The North American Menopause Society ·Sol Epstein, Grant R. Goodman	15
8	Bone Mass Measurements 1997 ·Trends in Endocrinology and Metabolism ·Sol Epstein, Paul D. Miller	16
9	Environmental risk factors for osteoporosis. 1994 ·Environmental Health Perspectives ·Robert A. Goyer, Sol Epstein, Maryka H. Bhattacharyya, Kenneth S. Korach, Joel G. Pounds	37
10	Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats 1993 ·Calcified Tissue International ·Ian I. Joffe, Ian Katz, (unknown), (unknown), Yogendra P. Kharode, Joseph Tamasi, Sol Epstein	39
11	Tamoxifen: disease prevention or disease substitution? 1992 ·The Lancet ·Adriane Fugh‐Berman, Sol Epstein	55
12	The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat 1990 ·Calcified Tissue International ·Neville Glajchen, S. Thomas, Paul S. Jowell, Sol Epstein, Firhaad Ismail, M D Fallon	15
13	The response of circulating parameters of bone mineral metabolism to ethanol- and EDTA-induced hypocalcemia in the rat 1990 ·Bone and Mineral ·S. Thomas, Colin Movsowitz, Sol Epstein, Paul S. Jowell, Firhaad Ismail	12
14	Bone-derived proteins 1989 ·Trends in Endocrinology and Metabolism ·Sol Epstein	6
15	Serum and Urinary Markers of Bone Remodeling: Assessment of Bone Turnover 1988 ·Endocrine Reviews ·Sol Epstein	132
16	Serum Bone Gla Protein and the Vitamin D Endocrine System in the Oophorectomized Rat 1988 ·Endocrinology ·Firhaad Ismail, Sol Epstein, Michael D. Fallon, S. Thomas, Timothy A. Reinhardt	84
17	Evidence for alteration of the vitamin D-endocrine system in obese subjects. breakdown → 1985 ·Journal of Clinical Investigation ·Norman H. Bell, Sol Epstein, A Greene, Judith Shary, Mary Joan Oexmann, S. Shaw	552
18	Herpes zoster of the chest wall and gynaecomastia. A case report. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Sol Epstein	2
19	Paget's disease of bone (osteitis deformans) treated with human synthetic calcitonin. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Sol Epstein, (unknown)	1
20	Disappearance rates of plasma growth hormone after intravenous somatostatin in renal and liver disease 1976 ·South African Medical Journal ·Sol Epstein, B. L. Pimstone, Derek Le Roith, S. Hendriks, S. M. Hamilton, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact